Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis

The neurofilament protein is a major structural protein of neurons and a marker for axonal damage. The concentrations of the light subunit of the neurofilament triplet protein (NFL) in CSF were significantly increased in patients with relapsing-remitting multiple sclerosis compared with healthy controls (p<0.001). Seventy eight per cent of patients with multiple sclerosis showed increased NFL concentrations. Significant correlations between the NFL concentration in CSF and clinical indices were discerned for disability, exacerbation rate, and time from the start of the previous exacerbation to the time of the lumbar puncture. The results suggest that axonal damage occurs during relapsing-remitting multiple sclerosis and that the damage contributes to disability and the appearance of clinical exacerbations. The concentration of NFL in CSF is a potential marker of disease activity in multiple sclerosis and might be useful in future clinical trials of multiple sclerosis.

[1]  C. Wikkelsø,et al.  Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF , 1996, Journal of neurochemistry.

[2]  L. Rosengren,et al.  Glial fibrillary acidic protein in CSF of multiple sclerosis patients: relation to neurological deficit , 1995, Journal of the Neurological Sciences.

[3]  A. Broocks,et al.  Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients a with multinle sclerosis , 1994, Neurology.

[4]  G. Barker,et al.  Correlation of magnetization transfer ration with clinical disability in multiple sclerosis , 1994, Annals of neurology.

[5]  G J Barker,et al.  Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. , 1994, Brain : a journal of neurology.

[6]  K. Haglid,et al.  Quantitative and Qualitative Alterations of Neuronal and Glial Intermediate Filaments in Rat Nervous System After Exposure to 2, 5‐Hexanedione , 1991, Journal of neurochemistry.

[7]  W. Mcdonald,et al.  The longstanding MS lesion. A quantitative MRI and electron microscopic study. , 1991, Brain : a journal of neurology.

[8]  A. Hamberger,et al.  The effect of anN-methyl-d-aspartate lesion in the hippocampus on glial and neuronal marker proteins , 1991, Brain Research.

[9]  Paul C. Letourneau Intrinsic determinants of neuronal form and function edited by R. J. Lasek and M. M. Black, Alan R. Liss, 1988. US$120.00 (xvii + 591 pages) ISBN 0 8451 2739 X , 1989, Trends in Neurosciences.

[10]  P J Airaksinen,et al.  The retinal nerve fiber layer, neuroretinal rim area, and visual evoked potentials in MS , 1988, Neurology.

[11]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[12]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[13]  C. W. Adams,et al.  The onset and progression of the lesion in multiple sclerosis , 1975, Journal of the Neurological Sciences.